top of page
ZZZZZ

Private Equity

드림스톤프라이빗에쿼티

Dreamstone Private Equity

Established in February 2019 and currently registered with Financial Supervisory Service (equivalent to SEC in the US) as General Partner for private equity funds, Dreamstone Private Equity is a global private equity firm based in Korea, specializing in PE/VC and real assets investment.

We invest across alternative asset classes covering buy-out, growth capital, real estate and aircraft investments. We are the very first private equity firm specializing in aircraft investments in Korea and serve many institutional investors, including pension funds, insurance companies, family offices, and other capital market investors.

Our team is comprised of distinguished professionals with a wealth of industry experience and track records. 

We pursue strategic growth opportunities to build value and seek to maximize continuous investment return to help our fund investors achieve their investment goals backed by a strong global network and a long experience.

What we do

We partner with many leading conglomerates and innovative companies in Korea to address their business needs in future growth and in capital resources. Our strategy is to seek untapped opportunities where we can add value while others overlook.

드림스톤프라이빗에쿼티

Our Portfolio

드림스톤프라이빗에쿼티

Plinemotors

2024 Korea.

An electric bus company experiencing rapid growth and leveraging asset-based lending (ABL) for investment

드림스톤프라이빗에쿼티

Eastar Jet​. 

2023 Korea.

Acquisition of stake in domestic low-cost carrier (LCC)

드림스톤프라이빗에쿼티

ATsens.

2023 Korea.

Researching and developing the world's smallest wearable patch type electrocardiogram measuring device system

드림스톤프라이빗에쿼티

Pino Bio​.

2022 Korea.

Innovative anticancer drugs investment of bio blind fund

드림스톤프라이빗에쿼티

TBT​. 

2022 Korea.

Defense-specialized thermal imaging camera manufacturer buy-out deal

드림스톤프라이빗에쿼티

Onecure gen.

2022 Korea.

Innovative anticancer drugs investment of bio blind fund

드림스톤프라이빗에쿼티

Autotelic Bio​.

2022 Korea.

Innovative anticancer drugs investment of bio blind fund

드림스톤프라이빗에쿼티

EnsolBio Sciences​. 

2022 Korea.

Innovative new drugs to cure the incurables investment of bio blind fund

드림스톤프라이빗에쿼티

Airovation Technologies.

2021 Korea.

Innovative Air-Tech company that provides original, patented air purification and carbon capture solutions investment

드림스톤프라이빗에쿼티

Kinosmedicine. 

2021 Korea.

Innovative medicines for brain diseases, cancers, and infectious disease investment of bio blind fund

드림스톤프라이빗에쿼티

Bertis​. 

2020 Korea.

Breast cancer early diagnosis biotech(series investment) NASDAQ and KOSDAQ listing candidate

드림스톤프라이빗에쿼티

Future Medicine​.

2020 Korea.

NASH treatment biotech series investment

Dreamstone partnersㅣAIP CapitalㅣBusiness Number : 268-88-01409

@ 2020 Dreamstone Partners All rights reserved.

bottom of page